AUTISM TREATMENT PLUS LIMITEDActive

Company number 08623707Private limited companyIncorporated 2013

Key figures

£8,119-12.5%
Net assets 2024/25
+200.9%
Average annual growth 2020/21–2024/25
02.5 k5 k7.5 k10 k2020/212021/222022/232023/242024/25

Like most small UK companies, AUTISM TREATMENT PLUS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 k10 k15 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand1,72012,1979,35211,74010,594
Total assets3,96413,15210,23014,35014,853
Total liabilities3,8654,4223,2185,0686,734
Net assets / total equity998,7307,0129,2828,119
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

86900

As described in the company's latest filed accounts.

Summary: AUTISM TREATMENT PLUS LIMITED

Company

AUTISM TREATMENT PLUS LIMITED is a private limited company registered with Companies House under company number 08623707. It was incorporated on 24 Jul 2013. Its status is active. The registered office is in London (W1B). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files abridged accounts (unaudited). Net assets were £8,119, down 12.5% on the previous year. Cash at bank and in hand was £10,594. Total assets were £14,853 and total liabilities £6,734. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 24 Jul 2027.